Concepedia

Bisphosphonate‐related osteonecrosis of the jaw and its associated risk factors: A belgian case series

Sven Saussez, Rokneddine Javadian, Chloé Hupin, Michèle Magremanne, Gilbert Chantrain, Isabelle Loeb, Christine Decaestecker

The Laryngoscope · 2009 · 74 citations · 14 references

DOIFull text

Open access

Abstract

Lesions smaller than 1 cm and lesions that were subject to medical treatments are associated with a better outcome. Surgical treatments appear to be non-beneficial for BROJ.

References

14

Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment

Robert E. Marx, Yoh Sawatari, Michel Fortin et al. · Journal of Oral and Maxillofacial Surgery · 2005 · 1.6K citations

, , +4

American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws—2009 Update

Salvatore L. Ruggiero, Thomas B. Dodson, Leon A. Assael et al. · Journal of Oral and Maxillofacial Surgery · 2009 · 1.3K citations

, , +10

Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors

Aristotle Bamias, Efstathios Kastritis, Christina Bamia et al. · Journal of Clinical Oncology · 2005 · 1.1K citations · Full text

American Society of Clinical Oncology 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women With Breast Cancer

Bruce E. Hillner, James N. Ingle, Rowan T. Chlebowski et al. · Journal of Clinical Oncology · 2003 · 970 citations

Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid

Jeanette M. Wood, Karine Bonjean, Stephan Ruetz et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 844 citations